Discovering Factors in Head and Neck Cancer Patients' Clinical Study Experiences
NCT05801770 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-04-06
Summary
Enrollment in clinical trials usually favors a particular demographic group. But there is limited research available to explain what study attributes affect the completion of these specific demographic groups.
This trial will evaluate the safety and efficacy of head and neck cancer treatments. The focus will be on tracking the rates of completion and withdrawal among these individuals.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future head and neck cancer studies.
Conditions
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-30
- Primary Completion
- 2025-04-30
- Completion
- 2026-04-30
More Related Trials
-
Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer
NCT01098669 ·Status: COMPLETED
-
A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC
NCT00483821 ·Status: COMPLETED
-
Chemo-embolization for Head and Neck Cancer
NCT04595981 ·Status: WITHDRAWN ·Phase: PHASE2
-
Low-Carbohydrate Normocaloric Diet in Patients With Head and Neck Carcinoma (HNC)
NCT02555176 ·Status: COMPLETED ·Phase: NA
-
Reconstructive Surgery For Head And Neck Cancer Patients
NCT00578032 ·Status: COMPLETED
-
H&N Cancer; Survivorship and Late Effects
NCT04758026 ·Status: COMPLETED
-
Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
NCT00002922 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer
NCT00483639 ·Status: COMPLETED
-
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT01349933 ·Status: COMPLETED ·Phase: PHASE2
-
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00020189 ·Status: COMPLETED ·Phase: PHASE2
-
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer
NCT00049140 ·Status: COMPLETED ·Phase: PHASE2
-
Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
NCT04319471 ·Status: UNKNOWN ·Phase: PHASE2
-
Docetaxel in Head and Neck Cancer
NCT00261703 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
NCT00058006 ·Status: COMPLETED ·Phase: PHASE2
-
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
NCT03010150 ·Status: RECRUITING
-
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
NCT03678649 ·Status: UNKNOWN ·Phase: PHASE2
-
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
NCT00544414 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-tumor Specific Immune Response in Head and Neck Cancers
NCT02881918 ·Status: UNKNOWN
-
Gene Therapy in Treating Patients With Advanced Head and Neck Cancer
NCT00009841 ·Status: COMPLETED ·Phase: PHASE1
-
Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
NCT00494182 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer
NCT01111942 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Efficacy of Smoking Cessation Intervention for Head and Neck Cancer Patients
NCT03786172 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study of Imatinib Cetuximab Combo for H & N Cancer
NCT05816785 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer
NCT00840814 ·Status: COMPLETED
-
Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
NCT06905145 ·Status: RECRUITING